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Prevalence and Risk Factors for Development of Hemorrhagic Gastro-Intestinal Disease in Veterinary 1 
Intensive Care Units in the United Kingdom 2 
Authors Final version with corrections 3 
Abstract 4 
Objective: To determine the prevalence of hemorrhagic gastro-intestinal (GI) disease developing in dogs 5 
and cats admitted for management of non-GI disease in veterinary intensive care units (ICUs). 6 
Design: Retrospective study of animals presented between October 2012 and July 2013. 7 
Setting: Three ICUs located in veterinary teaching hospitals in the United Kingdom. 8 
Animals: Dogs (n=272) and cats (n=94) were consecutively enrolled from three ICUs if they were 9 
hospitalized in the unit for at least twenty-four hours.  Cases were excluded if they had hemorrhagic GI 10 
disease in the forty-eight hour period before presentation or in the twenty-four hour period after 11 
admission.  Cases were also excluded if they suffered skull fracture, epistaxis or hemoptysis, if they 12 
underwent surgical procedures of the GI or upper respiratory tracts, or if they were presented for 13 
management of GI disease. 14 
Measurements and Main Results: Hemorhagic GI disease was observed in dogs at all three units, but at 15 
different rates (Center 1: 10.3%, Center 2: 4.8%, Center 3: 2.2%).  Hemorrhagic GI disease was not 16 
observed in cats at any of the participating centers.  Construction of a multivariable logistic regression 17 
model revealed that serum albumin concentration, administration of prophylactic gastro-protectant drugs 18 
and institution were significantly associated with the development of hemorrhagic GI disease in dogs.  19 
Development of hemorrhagic GI disease and placement of a feeding tube were significantly associated 20 
with mortality during the period of hospitalization in dogs.  Thirty-seven (13.6%) dogs and 12 (12.8%) 21 
cats died or were euthanized while hospitalized, with a higher mortality rate (42.1%) in dogs with 22 
hemorrhagic GI disease.    23 
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Conclusions: Hemorrhagic GI disease does develop in dogs hospitalized for management of non-GI 24 
disease, but this phenomenon was not observed in cats.  Development of hemorrhagic GI disease 25 
appeared to have a significant impact on survival in veterinary ICUs. 26 
 27 
Keywords: Stress-related mucosal disease, stress ulcer prophylaxis, omeprazole, enteral feeding 28 
 29 
Introduction 30 
In human medicine, stress-related mucosal disease (SRMD) refers to the development of erosive 31 
lesions of the stomach and intestines in patients admitted to ICUs for management of severe illness1.  The 32 
term covers a spectrum of disease, from superficial mucosal injury detectable only by 33 
gastroduodenoscopy to severe ulceration that results in clinically important hemorrhage.  Overt clinical 34 
bleeding due to SRMD was reported to occur in approximately 4% of humans admitted to a group of 35 
ICUs in Canada2, and development of this disease significantly increased the risk of death during the 36 
period of hospitalization. 37 
 38 
Impaired perfusion of the gastric mucosal barrier (GMB) is the proximate cause of SRMD, but 39 
development of the disease is reflective of systemic changes in hemodynamic status and inflammatory 40 
cascade3.  Splanchnic hypoperfusion caused by sympathetic stimulation or hypovolemia is likely to be an 41 
important factor in the development of SRMD but it may be difficult to detect in patients that appear to 42 
have adequate macrohemodynamic markers of systemic perfusion4.  Reduced splanchnic blood flow also 43 
increases the risk of reperfusion injury caused by oxygen free radicals if blood flow is restored after 44 
appropriate resuscitation5.  Local or systemic production of pro-inflammatory cytokines such as tumour 45 
necrosis factor alpha and interleukins 1 and 8 causes further alterations in perfusion of the gastric mucosa 46 
and disrupts the production of mucus and bicarbonate6, which are required for neutralization of gastric 47 
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acid.  If the GMB is sufficiently disrupted by these changes, gastric acid may cause direct damage to the 48 
mucosa, and this process can progress to cause substantial ulceration and hemorrhage.     49 
 50 
Several factors have been identified in human patients that increase the risk of development of 51 
SRMD2, particularly respiratory failure necessitating mechanical ventilation and coagulopathy.  52 
Administration of prophylactic gastro-protectant medications reduces the risk of SRMD2, but this may be 53 
associated with development of other complications, such as aspiration pneumonia, because increased 54 
gastric pH permits bacterial colonization of the stomach13.       55 
 56 
Hemorrhagic GI disease has not been described specifically in veterinary ICUs, but two studies 57 
identified subclinical gastric erosions in dogs that underwent decompressive surgery for intervertebral 58 
disc disease, some of which also received glucocorticoids7,8.  These lesions did not appear to be 59 
responsive to administration of gastro-protectant medications.  The pathogenesis of gastric ulceration in 60 
Alaskan sled dogs at the Iditarod race may also share some features with that of SRMD in people.  61 
Strenuous exercise in these dogs resulted in increased gastric permeability and increased frequency of 62 
gastric lesions observed by endoscopy9,10.  The authors of this study speculated that these changes could 63 
occur due to increased circulating glucocorticoid concentrations or diversion of cardiac output to skeletal 64 
muscle for exercise.  Two further studies described development of gastroduodenal ulceration in critically 65 
ill animals in association with various underlying causes, including hepatic disease, pancreatitis, 66 
hypoadrenocorticism, and administration of non-steroidal anti-inflammatory drugs (NSAIDs)11,12.   67 
 68 
The primary aim of this study was to determine the proportion of animals that developed overt 69 
hemorrhagic GI disease in veterinary ICU patients.  It was hypothesized that this would occur at similar 70 
rates to those reported in human ICUs, and that dogs would develop the disease more frequently than cats 71 
based on previous evidence suggesting that the GI tract is not the shock organ of cats.  Secondary aims 72 
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were to investigate risk factors for the development of hemorrhagic GI disease, and to determine whether 73 
development of these signs was associated with mortality during the period of hospitalization.       74 
 75 
Materials and Method 76 
Study design  A retrospective multi-center survey was conducted at three intensive care units 77 
(Centers 1, 2 and 3) located in teaching hospitals in the UK.  These units accept referral cases from 78 
veterinarians in general practice and from other specialist services within the same institutions.  Case 79 
management in each unit is supervised by board certified clinicians in emergency and critical care, 80 
internal medicine, surgery or neurology.  Entry and egress of patients from the ICUs and use of any drugs, 81 
including gastro-protectant medications, were at the discretion of the attending clinician.   82 
 83 
All cases presenting consecutively to the ICUs were considered eligible for enrolment during the 84 
period of the study if they were hospitalized for at least twenty-four hours.  Cases were excluded if they 85 
had a history of hemorrhagic GI disease in the forty-eight hours prior to hospitalization or if they 86 
developed signs within the first twenty-four hours after admission.  Cases were also excluded if they 87 
underwent surgical procedures involving the GI or upper respiratory tracts, if they presented with or 88 
developed epistaxis or hemoptysis, if they presented for management of GI disease, or if they had 89 
sustained one or more skull fractures.  Cases were not excluded if they received gastro-protectant drugs, 90 
NSAIDs, glucocorticoids or anticoagulants prior to admission or during hospitalization, nor if they were 91 
diagnosed with diseases that may cause secondary GI signs, such as hypoadrenocorticism.   92 
 93 
Data collection:  A single entry form was produced for each case enrolled in the study 94 
(Supplementary Data 1), and this was completed by a veterinarian after the patient was discharged from 95 
the ICU.  The veterinarian completing the enrolment form did not necessarily have primary responsibility 96 
for the case.  The following data were collected from the medical records of each case: signalment, 97 
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presenting problem and problems identified after initial consultation, concurrent diseases and 98 
medications, clinical examination findings, GI signs observed while hospitalized, and results of complete 99 
blood cell count, serum biochemistry and coagulation profiles performed on admission.  Types of feeding 100 
tube placed in individual patients were recorded, as were the types and doses of any gastro-protectant, 101 
NSAID, glucocorticoid or antithrombotic medications administered in the ICU.  The length of 102 
hospitalization, the nature of any surgical procedures conducted immediately before or during the period 103 
of ICU hospitalization, and mortality or euthanasia while hospitalized were also noted.      104 
 105 
SRMD was defined as hemorrhagic GI disease manifesting as hematemesis, melena or 106 
hematochezia or as mucosal erosions and hemorrhage observed during GI endoscopy.  Dogs were 107 
diagnosed with systemic inflammatory response syndrome (SIRS) if they fulfilled two or more of the 108 
following four conditions:  rectal temperature <37.2C or >39.2C, heart rate >140 beats per minute, 109 
respiratory rate >30 breaths per minute, or total white blood cell count <6x109/l (6,000/µl) or >19x109/l 110 
(19,000/µl)15. 111 
 112 
Statistical analysis:  All statistical analyses were conducted using a commercial software 113 
programa.  Shapiro-Wilks tests and visual assessments of histograms were used to determine whether 114 
variables were parametrically distributed.  Parametric and non-parametric variables were compared using 115 
Student’s t tests and Mann-Whitney U tests, respectively.  Categorical data were compared using Fisher’s 116 
exact tests or Chi squared tests.  Confidence intervals, where stated, are at the 95% level.     117 
 118 
The proportion of veterinary patients that developed SRMD was determined by dividing the 119 
number of cases with hematemesis, melena or hematochezia by the total number of included cases 120 
collectively and for each ICU, and 95% confidence intervals were calculated.   121 
 122 
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Multivariable logistic regression was used to evaluate risk factors for development of SRMD and 123 
for mortality during hospitalization.  Univariable analyses were first conducted using Mann-Whitney U 124 
tests, Chi squared tests or Fisher’s exact tests, and variables with p values <0.2 were retained.  These 125 
variables were entered together in the multivariable analysis, and a model was fitted using a forward entry 126 
method based on calculation of likelihood ratios.  A categorical variable describing whether prophylactic 127 
gastro-protectant medications were administered was forced into the final model for development of 128 
SRMD, and a variable describing whether cases fulfilled the SIRS criteria was forced into the model of 129 
mortality as these factors were considered to be of considerable a priori importance for each model based 130 
on published evidence2,16.  Institute was included as a factor in both models to account for possible 131 
differences between centers.   Hosmer-Lemeshow tests were performed to assess the adequacy of model 132 
fit, and receiver operator characteristic (ROC) curves were produced using probabilities derived from 133 
each logistic regression model to determine the predictive capability of each model.     134 
 135 
Results 136 
Study populations: After removal of duplicate cases and application of exclusion criteria, 272 137 
dogs and 94 cats were included in the study (Figure 1).  Of the dogs included, 159 (58.5%) were from 138 
Center 1, 21 (7.7%) were from Center 2, and 92 (33.8%) were from Center 3.  Of the cats, 67 (71.3%) 139 
were from Center 1, 7 (7.4%) were from Center 2, and 20 (21.3%) were from Center 3.  Seventy-one dogs 140 
were intact males, 37 intact females, 82 neutered males and 82 neutered females, whereas 3 cats were 141 
intact males, 4 intact females, 51 neutered males and 36 neutered females. 142 
 143 
  There was no difference in median age between dogs and cats, nor between animals of either 144 
species at different centers. 145 
   146 
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Prevalence of GI disease:  The proportion of dogs that developed SRMD was 10.3% (CI: 6.3-147 
15.7) at Center 1, 4.8% (CI: 0.85-22.7) at Center 2 and 2.2% (CI: 0.6-7.7) at Center 3, with a combined 148 
proportion of 7.0% (CI: 4.5-10.7).  The difference in proportions between centers was not significant (Chi 149 
square 5.2, p=0.075).  SRMD did not occur in any of the cats observed during this study at any center.  150 
Among the dogs that received prophylactic gastro-protectant medications, the proportion that developed 151 
SRMD was 16.4% (CI: 8.9-28.3), compared to 4.2% (CI: 2.2-7.8) in dogs that did not receive 152 
prophylaxis, and there was a significant difference in these proportions (Chi square 10.3, p=0.001).  Rates 153 
of development of SRMD during hospitalization in dogs and cats at each center are shown in Table 2.   154 
 155 
Of the dogs that developed SRMD (n=19), the most common diagnoses were immune-mediated 156 
disease (4), neoplasia (2), trauma (2), and Angiostrongylus vasorum infestation (2).  The remaining dogs 157 
were diagnosed with pyelonephritis (1), fasciitis (1), traumatic brain injury (1), hepatic disease (1), 158 
intervertebral disc protrusion (1), hypoadrenocorticism (1), sudden acute retinal degeneration syndrome 159 
(1), sepsis and disseminated intravascular coagulation (1), and intra-abdominal hemorrhage following 160 
ovariohysterectomy (1).      161 
 162 
Feeding tubes were placed in 27 animals across all centers.  Only esophagostomy tubes were 163 
placed in cats (n=7), but naso-esophageal (n=12), esophagostomy (n=5) and gastrostomy (n=3) tubes 164 
were placed in dogs.  The majority of the tubes were placed at Center 1 (n=23), with a smaller number at 165 
Center 3 (n=4).  Placement of a feeding tube was undertaken at Center 1 after a median period of anorexia 166 
of 3 days (IQR: 3-5, range 2-9, n=13).  The duration of anorexia could not be determined in 6 dogs, and a 167 
naso-esophageal feeding tube was placed in the remaining 4 dogs as a standard preparation for 168 
mechanical ventilation.     169 
 170 
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Evaluation of risk factors for development of SRMD: Univariable analyses revealed that 171 
multiple factors were associated with development of SRMD (Table 3).  When these variables were 172 
entered into the multivariable analysis, decreased serum albumin concentration, institute and 173 
administration of prophylactic gastro-protectant medications were retained in the final model.  Dogs with 174 
SRMD were 4.3 (CI: 1.2-15.5) times more likely to have decreased serum concentrations of albumin, 4.3 175 
(CI: 1.4-13.7) times more likely to have received prophylactic gastro-protectant medications and 10.0 (CI: 176 
1.7-33.3) times less likely to have been hospitalized at Center 3 than those that did not develop SRMD.  177 
Performance of the Hosmer-Lemeshow test indicated good model fit (Chi Square 2.2, p=0.826), and the 178 
area under the ROC curve constructed using model probabilities was 0.79 (CI: 0.68-0.90)(Supplementary 179 
Figure 1A), showing that the model was able to discriminate adequately between cases with and without 180 
SRMD.  A ROC curve was also generated using individual values for serum albumin concentration 181 
(n=201), and the area under the curve was smaller using this model (0.68, CI: 0.52-0.84)(Supplementary 182 
Figure 1B).  Using a cut-off value of 28.0 g/l (2.8 g/dl), the sensitivity and specificity values for 183 
prediction of development of SRMD were 0.67 and 0.62, respectively. 184 
 185 
Hospitalization and survival:  The median durations of hospitalization and mortality rates for 186 
dogs and cats at different centers are shown in Table 2.  There was no difference in duration of 187 
hospitalization between cats and dogs from all centers, but average length of hospitalization was greater at 188 
both Centers 2 (p=0.048) and 3 (p<0.001) compared to Center 1.  Thirty-seven (13.6%) dogs and 12 189 
(12.8%) cats died or were euthanized while hospitalized.  Mortality rates were similar between centers 190 
and species, but the proportion of dogs with SRMD that did not survive to discharge (8/19 dogs, 42.1%) 191 
was significantly greater than for dogs that did not develop SRMD (29/252, 11.5%; Chi square 14.0, 192 
p<0.001).   193 
 194 
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Evaluation of risk factors for mortality during hospitalization: Significant associations were 195 
detected between several variables and mortality during hospitalization using univariable analysis (Table 196 
4).  When these variables were entered into the multivariable analysis, placement of a feeding tube and 197 
development of SRMD were associated with mortality.  Dogs that died or were euthanized while 198 
hospitalized were 13.3 (CI: 4.0-43.5) times more likely to have had a feeding tube placed and 5.1 (CI: 199 
1.6-15.9) times more likely to have developed SRMD than those that were discharged.  Fulfilment of the 200 
SIRS criteria and institute were forced into the final model, but these variables were not significantly 201 
associated with mortality.  The model fit was adequate (Hosmer-Lemeshow Chi square 5.7, p=0.338), and 202 
generation of a ROC curve using model probabilities yielded an area under the curve of 0.77 (CI: 0.68-203 
0.86)(Supplementary Figure 2).           204 
 205 
Naso-esophageal feeding tubes were placed routinely in dogs that were mechanically ventilated.  206 
When these animals were excluded from the analysis (n=4), the odds ratio for tube placement decreased 207 
to 8.5 (CI: 2.4 – 30.3, p=0.001), while that for development of SRMD did not change considerably (OR: 208 
5.1, CI: 1.6 – 15.9, p=0.006).  Model fit parameters were similar to those reported above (data not 209 
shown).      210 
 211 
Discussion 212 
The results of this study show that hemorrhagic GI disease, defined here as SRMD, does occur in 213 
dogs hospitalized in veterinary ICUs, but was not observed in any of the cats that were included.    Dogs 214 
with SRMD were more likely to have decreased serum concentrations of albumin on presentation, but this 215 
parameter had a low sensitivity and specificity for prediction of development of this disease.  Affected 216 
animals were also more likely to have received prophylactic gastro-protectant medications and less likely 217 
to have been hospitalized at Center 3.  SRMD and placement of a feeding tube were significantly more 218 
likely to occur in dogs that died or were euthanized while hospitalized. 219 
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 220 
The proportion of dogs that developed SRMD varied considerably between Centers, and dogs at 221 
Center 3 were at significantly reduced risk compared to either Center 1 or 2.  The cause of this difference 222 
is not apparent: SRMD could have developed at similar rates at Centers 2 and 3 as at Center 1 but was not 223 
recorded, although the authors consider this scenario to be unlikely as occurrence of all forms of GI 224 
disease is considered to be a notable event among nursing staff and attending clinicians at all three 225 
centers.  The true prevalence of SRMD at Center 2 may also differ from that reported due to the small 226 
number of cases observed in this study, as indicated by the wide confidence intervals for this parameter. 227 
 228 
Measurable hemorrhage due to stress-related GI injury is reported to occur in approximately 4-229 
6% of affected humans2,16, which is broadly comparable to the proportion of dogs affected with SRMD 230 
defined according to this study.  In contrast to human intensive care, none of the animals included in this 231 
study underwent gastroduodenoscopy, which is a much more sensitive technique for detection of 232 
superficial erosions in the acid-secreting sections of the stomach.  When this technique was applied in 233 
dogs undergoing surgery for management of inter-vertebral disc disease, subclinical lesions were 234 
observed in approximately 75% of patients7,8.  The animals considered in this study are therefore likely to 235 
represent the most severely affected patients in a spectrum of stress-related GI disease, similar to the 236 
syndrome of clinically important bleeding in humans with SRMD.    237 
 238 
SRMD was not observed in any of the 94 cats that were included in this study, and this finding is 239 
consistent with the hypothesis that the GI tract is not a ‘stress organ’ in cats.  Previous experimental17 and 240 
epidemiologic18,19 studies indicate that cats are susceptible to pulmonary injury when suffering from 241 
systemic inflammation or sepsis, and there are no previous reports suggestive of SRMD in this species.  242 
Observation of a greater number of cats in ICUs is likely to be required to determine whether SRMD 243 
occurs at lower prevalence than could be detected during this study.   244 
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 245 
Dogs that developed SRMD were more likely to have decreased serum albumin concentrations at 246 
presentation.  Albumin is an essential product used in maintaining the GMB, and dogs with decreased 247 
albumin concentrations are reported to be at increased risk of dehiscence following incisional biopsy of 248 
the small intestine20.  It is therefore possible that dogs with hypoalbuminemia are at increased risk of 249 
SRMD and other GI signs due to their inability to maintain an effective mucosal wall.  Alternatively, the 250 
albumin concentration could be decreased in patients that have clinically undetectable GI injury resulting 251 
in increased GI permeability and protein-losing enteropathy, prior to the onset or recognition of 252 
hemorrhagic GI disease.  Investigation of Alaskan sled dogs indicated that increased gastric permeability 253 
was an early event in development of erosive gastric disease in this cohort10, suggesting that 254 
hypoalbuminemia could be an effect rather than a cause of the GI signs observed.   Hypoalbuminemia in 255 
this study may also represent a non-specific marker of illness, as serum albumin is a negative acute phase 256 
protein.  Decreased serum concentrations of albumin have also been identified as negative independent 257 
prognostic factors in two studies of dogs admitted to veterinary ICUs21,22.   258 
 259 
With a cut off value of 28.0 g/l (2.8 g/dl, the lower limit of the reference range in use at Center 1), 260 
serum albumin concentration had a poor sensitivity and specificity for prediction of the development of 261 
SRMD, limiting the usefulness of this parameter in guiding the use of prophylactic interventions.  Further 262 
studies will be required to establish whether patients with hypoalbuminemia would benefit from 263 
administration of gastro-protectant medications.       264 
 265 
Gastro-protectant medications were administered to a large proportion of the animals included in 266 
this study, which complicated the interpretation of the results obtained, particularly because animals that 267 
ultimately developed SRMD were more likely to have received one or more of these products.  This 268 
variable was included when fitting the logistic regression model due to its a priori importance2, but it 269 
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would have been preferable to evaluate groups of treated and untreated dogs separately in a stratified 270 
model23.  This approach was not attempted in this study as the number of cases in each subgroup would 271 
have been insufficient to evaluate the number of risk factors included.       272 
 273 
Univariable analysis identified several other factors that were significantly associated with 274 
development of SRMD, including several that have previously been associated with the analogous disease 275 
in humans, such as hepatopathy, nephropathy and thrombocytopenia.  Cook and colleagues2 reported 276 
hepatic and renal failure as significant risk factors for development of clinically important bleeding after 277 
univariable analysis, but only secondary coagulopathy and respiratory failure necessitating mechanical 278 
ventilation were retained in the multivariable model.    Failure to identify these variables as risk factors 279 
for SRMD in this study probably relates to the relatively low prevalence of these problems in this sample, 280 
and in veterinary ICU caseloads in the UK.   281 
 282 
SRMD and placement of a feeding tube were significantly more likely to occur in dogs that died 283 
or were euthanized compared to those that were discharged.  Placement of a feeding tube is considered to 284 
be a relatively benign procedure24 and, in this group of patients, was usually performed at the same time 285 
as imaging or other procedures that necessitated general anesthesia or sedation.  Placement of a feeding 286 
tube in this model is more likely to be a proxy variable that could represent a prolonged history of 287 
anorexia or anticipated anorexia, or a patient likely to require a long period of intensive care following 288 
placement.  Feeding tubes were also placed in four patients in preparation for mechanical ventilation, 289 
which is also likely to be a poor prognostic indicator in veterinary ICU patients25.  The authors do not 290 
consider that use of a feeding tube per se should increase the risk of death as this procedure is usually 291 
well tolerated or is associated with only minor complications24.  Procedures are also employed at all three 292 
centers to minimize the risk of refeeding syndrome in dogs with prolonged anorexia. 293 
 294 
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Evidence from human medicine suggests that enteral nutrition should be beneficial for patients 295 
with stress-related GI disease26, and early re-introduction of enteral feeding may reduce the requirement 296 
for gastro-protectant medications.  A recent pilot study of dogs with pancreatitis further indicated that 297 
enteral feeding was well tolerated in critical care patients and was not associated with a greater prevalence 298 
of adverse effects compared to administration of parenteral nutrition27, and a study of dogs with septic 299 
peritonitis suggested that introduction of early enteral nutrition was associated with shorter duration of 300 
hospitalization28.  Nevertheless, it remains to be determined in future studies whether re-introduction of 301 
enteral nutrition would prevent the hemorrhagic GI disease reported in patients in this study.    302 
 303 
Development of hemorrhagic GI disease in patients that did not present for investigation or 304 
management of GI disease is likely to cause increased morbidity, either due to development of anemia, 305 
production and release of further inflammatory mediators, or increased risk of bacterial translocation 306 
across the wall of the stomach or upper small intestine.  SRMD may itself act as a proxy variable for 307 
severe systemic disease, such as SIRS, sepsis, or multiple organ dysfunction syndrome (MODS).  A 308 
variable describing fulfilment of established SIRS criteria was included in the final model of factors 309 
associated with mortality during hospitalization to try to account for this possibility as this factor was 310 
shown to be significant in a previous study15.  Despite this, development of SRMD remained an 311 
independent predictor of mortality, and the higher risk of mortality among patients that developed SRMD 312 
is consistent with findings in humans with overt clinical hemorrhage due to GI disease2. 313 
 314 
Limitations:  Limitations of this study include the relatively small number of cases included, 315 
especially for investigation of risk factors for development of SRMD and mortality.  Animals with SRMD 316 
were more likely to have been hospitalized at Centers 1 and 2 than Center 3, and, although institution was 317 
included as an independent factor in all multivariable analyses, it is possible that unmeasured differences 318 
between centers could have acted as confounding or modifying factors.   319 
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 320 
Although much of the data included in this study was collected prospectively, some information 321 
regarding development of GI disease was collected retrospectively from clinical records, reducing the 322 
reliability and consistency of these findings.  Data were also collected by a number of different 323 
investigators who may not have been involved in the primary care of the case. 324 
 325 
Conclusions:  SRMD was observed in dogs from three different veterinary ICUs but was not 326 
observed in cats.  Decreased serum albumin concentration was associated with development of SRMD, 327 
but, using a clinically relevant cut off value, this variable had a poor sensitivity and specificity for 328 
prediction of the disease.  Development of SRMD and placement of a feeding tube were independently 329 
associated with increased mortality while hospitalized, but further studies will be required to determine 330 
the effects and potential benefits of prophylactic gastro-protectant therapy in veterinary ICU patients. 331 
 332 
Footnotes 333 
a IBM Corp. Released 2011. IBM SPSS Statistics for Windows, Version 20.0.  Armonk, NY: IBM Corp. 334 
 335 
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